Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"Filing in Europe is definitely the best course of action for Anavex."
Hopefully the BlackRock - Vanguard BP owned tentacles don't reach that far. 🤞 It's a real problem.
We may need to look at Asian Markets. They don't like U.S. corruption.
The planet is getting smaller..
Maria Bartiromo and Byron Donalds think Obama's controlling country through 'earpiece'
Interesting read. Good discussion with Larry Kudlow and Byron Donald's
https://www.msn.com/en-us/news/politics/maria-bartiromo-and-byron-donalds-think-obamas-controlling-country-through-earpiece/ar-AA1ppaHk?ocid=BingNewsSerp
Why should you ask for a confirmation P4 trial? Anavex has already proved Blarcamesine is the safest drug in the CNS space. It should be approved with the level of urgency as Covid -19. We want access to Blarcamesine now. imo
Never seen a time like this in my 63 years of life. People who are in charge hate our country. Almost unbelievable. Good thing Trump comes back on November 5
Almost Unbelievable!!
Biden-Harris admin loses track of 320,000 migrant children — with untold numbers at risk of sex trafficking and forced labor
https://www.msn.com/en-us/news/crime/biden-harris-admin-loses-track-of-320000-migrant-children-with-untold-numbers-at-risk-of-sex-trafficking-and-forced-labor/ar-AA1pcO8c
People have seen enough with patients on the drug for over eight years. We want access to Blarcamesine now. imo
Blarcamesine sustains benefits in early Alzheimer’s patients over year
Oral therapy found to slow cognitive, functional decline in Phase 2b/3 trial
https://alzheimersnewstoday.com/news/blarcamesine-sustains-benefits-early-alzheimers-over-year-data/
AAIC 2024 have shown the world the Blarcamasine 2-73 drug trial results. Criminals are in place to question and doubt everything reported. Even from the top professionals in the CNS world. We demand access to Blarcamasine now. imo
Yes. We have seen enough documentation and drug trial results of Blarcamosine 2-73. We have seen eight years and more real life results from people taking this drug. Many if not all who have stayed with the drug have shown some improvement to some degree, or even recovery reversal. We the people of the world demand access to this drug immediately. It should be approved and distributed at the urgency level we saw with Covid-19. We want access to Blarcamasine now. imo
US employment falls by 818,000 in latest government revision
Largest revision in 15 years...
Big economic depression coming from Dem's policies.
https://finance.yahoo.com/news/us-employment-falls-by-818000-in-latest-government-revision-144414848.html
BS - AAIC 2024 have shown the world of the drug trial results. Criminals are in place to question and doubt everything reported. Even from the top professionals in the CNS world. It's time to demand access to the drug. imo
People need to demand access to Blarcamasine 2-73. Let the people know that BP is working hard to keep it away from the people in need. Many if not all who have stayed with the drug have shown some improvement to some degree, or even recovery reversal. 2-73 is the cleanest safest drug in the CNS space. Imo
Thanks for the great post george. Keep them coming.👍️
https://www.biotechtoinvest.com/research/2022/5/15/the-answer-was-here-all-the-time-why-anavex2-73-can-stop-alzheimers-disease
All I want is 2-73 .. In Cabo San Lucas...It's not much to ask .is it..via Tijuana`~
https://video.search.yahoo.com/search/video?fr=mcafee&p=beast+of+burden+keith+richards&type=E210US105G0#action=view&id=1&vid=dd43eb0e4f611fe9092e1b3d4f907761
COVID-19 Associated With Long-Term Cognitive Dysfunction, Acceleration of Alzheimer’s Symptoms
New research reported at the Alzheimer’s Association International Conference® (AAIC®) 2021, held virtually and in Denver found associations between COVID-19 and persistent cognitive deficits, including the acceleration of Alzheimer’s disease pathology and symptoms.
Biological markers of brain injury, neuroinflammation and Alzheimer’s correlate strongly with the presence of neurological symptoms in COVID-19 patients.
Blarcamasine 2-73 could play even a greater role with this accelerated problem due to Covid -19
https://scitechdaily.com/covid-19-associated-with-long-term-cognitive-dysfunction-acceleration-of-alzheimers-symptoms/
"Way too much hand waving," With the MABS. The approved MABS cause brain bleeding and death. It's approved by the FDA.
We have no brain bleeding and death with Blarcamasine 2-73 ( Spelling for you Bio Lol.) Many if not all who have stayed with the drug have shown some improvement to some degree, or even recovery reversal. 2-73 is the cleanest safest drug in the CNS space.
Right! If SAVA put these results out they would be $150.00 a share in a week.
COVID-19 Associated With Long-Term Cognitive Dysfunction, Acceleration of Alzheimer’s Symptoms
https://scitechdaily.com/covid-19-associated-with-long-term-cognitive-dysfunction-acceleration-of-alzheimers-symptoms/
Patients have been taking Blarcamazine 2-73 for eight years now or even longer. Many if not all who have stayed with the drug have shown some improvement to some degree, or even recovery reversal. 2-73 is A+ in safety. We currently have FDA approved drugs that caused brain bleeding and even death. That is our competition. No brain bleeding here.
nidan7500
Some of us expect the FDA to refine their position and to acknowledge the AVXL results as (at least) encouraging . It is hard to understand the risks they might think they are protecting/preventing AVXL (potential patients) from. No other trials have shown AVXL safety or functional results even close to what AVXL has proven possible.
Cassava Sciences: New CEO, Same Old Problems
Cassava Sciences: Indictments Cast Long Shadows on Alzheimer's Trials - the end of simufilam's development for Alzheimer's.
https://seekingalpha.com/article/4712368-cassava-sciences-new-ceo-same-old-problems?mailingid=36362791&messageid=must_reads&serial=36362791.997453&source=email_must_reads&utm_campaign=Must%2BReads%2Brecurring%2B2024-08-09&utm_content=seeking_alpha&utm_medium=email&utm_source=seeking_alpha&utm_term=must_reads
"IMO, this is hard ball driven by his only leverage point...if he proves the stuff works he has them and we all win." Agree nidan. Patients have been taking Blarcamazine 2-73 for eight years now or even longer. Many if not all who have stayed with the drug have shown some improvement to some degree, or even recovery reversal. 2-73 is A+ in safety. We currently have FDA approved drugs that caused brain bleeding and even death. That is our competition. No brain bleeding here.
Shorts are panicking this morning. Trying to over run the message board. Buy signal.
Nice call georgejjl , but when the chips are down, I'll bet it Merck & Co. in the end. Buy out off Anavex Life Sciences for $165.00 per share or about > $14 Billion MC . Smok'in deal for all. GLTU
"Is this as massive as I think it is??" It should be nidan. Can you imagine if SAVA or ANVS had this write up and the recent AAIC data release AVXL shared? Their stock would bee $100.00 plus in a week.
https://www.neurologylive.com/view/blarcamesine-shows-significant-slowing-alzheimer-disease-phase-2-3-trial
That sounds good to me, georgejjl. Sign me up for 50 mg. Blarcamazine 2-73 once per day 90 day supply for two years. Delivered to my home via UPS, Fed Ex, Amazon or U.S. Mail.
Thank you
bb
Your working pretty hard today..
AAIC Blarcamaine data release is block buster news for Alzheimer's disease. No brain bleeding here.
Blarcamesine significantly slowed clinical progression by 38.5% and 34.6% at 48 weeks in 50 mg and 30 mg groups vs. placebo, respectively, on the prespecified primary cognitive endpoint ADAS-Cog13.
Blarcamesine significantly slowed brain atrophy in key regions of interest, including the whole brain by 37.6%, total grey matter by 63.5%, and lateral ventricles by 25.1%.
Blarcamesine demonstrated numerically superior clinical efficacy to approved therapies while also slowing neurodegeneration in early AD patients.
https://finance.yahoo.com/news/neurodegenerative-disease-focused-anavex-life-123916806.html
Berkshire halves Apple stake, boosts cash to $277 billion as it gets 'defensive’
Berkshire's cash stake grew to $276.9 billion as of June 30 from a then-record $189 billion three months earlier, largely because Berkshire sold a net $75.5 billion of stocks.
https://www.reuters.com/business/finance/berkshires-cash-hits-277-bln-buffett-slashes-apple-stake-operating-profit-sets-2024-08-03/
Just look at the Blarcamazine 2-73 data and compare it to the MAB's. Safety first...👏
We should start seeing brokerage firms strong buy upgrade post AAIC convention with better than current SOC drug trial results on Blarcamazine 2-73. Currently with a ridiculously low $550 million MC.
“In the beginning of a change the patriot is a scarce man, and brave, and hated and scorned. When his cause succeeds, the timid join him, for then it costs nothing to be a patriot.”
? Mark Twain
Intel to lay off more than 15% of its workforce as it cuts costs to try to turn its business around
https://www.msn.com/en-us/money/companies/intel-to-lay-off-more-than-15-of-its-workforce-as-it-cuts-costs-to-try-to-turn-its-business-around/ar-BB1r2MOD?ocid=BingNewsSerp
This country won't survive another year of this insanity. Trump the only way to fix the incredible damage done over the past four years. Maybe the only one who can stop a coming world war 3.
Yes, I recall reading that Anavex adjustment somewhere over the past five years.
Nice post, bas - A Comparison of the ADAS-Cog Scores for Aducanumab, Blarcamesine, Donanemab and Lecanemab!
2024 07/30 👏
Anavex Blarcamazine 2-73 is a superior drug.
Conclusions
Clearly, from this chart Blarcamesine has substantially better performance than the other drugs. The Blarcamesine trial had no inclusions or exclusions based on any tau or plaque or alleles. It is roughly 50% better than the "MABs".
Aducanumab, Donanemab and Lecanemab are monoclonal antibody drugs, frequently referred to as MABs. There were three different MAB drugs, independently developed by different companies, showing similar results. This data seems to raise the question, "Have the MABs reached their limit (approximately 27%) in slowing cognition decline?"
Right!! Anavex derangement syndrome...
Probably backed by Biogen..They are worried that NO BRAIN BLEEDING and death with Blarcamazine 2-73..
Anavex: An Update To Their Phase 2b/3 Alzheimer's Trial Data
Jul 30, 2024 07:16 PM | Anavex Life Sciences Corp.(AVXL) | By: C. C. Abbott
New update just now out. I don't have full access to article. Someone w/ access please post. TIA
https://seekingalpha.com/article/4708238-anavex-update-to-phase-2b3-alzheimers-trial-data?mailingid=36241744&messageid=2800&serial=36241744.572&source=email_2800&utm_campaign=rta-stock-article&utm_medium=email&utm_source=seeking_alpha&utm_term=36241744.572